The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies

Background Observational studies suggest an association between the incidence of rheumatoid arthritis (RA) and the prevalence of metabolic syndrome (MetS). However, the relationship between RA and MetS is controversial and research in this area is currently lacking. Objective The aim of this study was to assess whether the prevalence of MetS was higher in a group of RA patients compared to subjects without RA. Design A PubMed database search was conducted during April 2013 to identify observational studies of RA and risk of MetS. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the study design, the characteristics of the study participants, exposure and outcome assessments, and the method used to control for potential confounding factors. A random-effects model was used for the risk estimates. Results Our meta-analysis of four cross-sectional controlled studies plus eight case-control studies involving a total of 2283 cases and 4403 controls identified a significant association between RA and risk of MetS, with an overall OR of 1.24 (95% CI, 1.03-1.50). Conclusion This meta-analysis provides further evidence supporting patients with RA have a higher prevalence of MetS than subjects without RA. In addition, the geographic region of the population and the criteria used for MetS diagnosis could influence the association. However, these observations would need to be evaluated using prospective, randomized studies.

[1]  P. Raggi,et al.  Association of Epicardial Adipose Tissue With Cardiometabolic Risk and Metabolic Syndrome in Patients With Rheumatoid Arthritis , 2013, Arthritis care & research.

[2]  Ji-Min Kim,et al.  Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects? , 2013, The Korean journal of internal medicine.

[3]  J. Shults,et al.  Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. , 2012, The American journal of medicine.

[4]  S. Shoelson,et al.  Metabolic Syndrome, Insulin Resistance, and Roles of Inflammation – Mechanisms and Therapeutic Targets , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Sarıyıldız,et al.  The Relationship of Metabolic Syndrome With Disease Activity and the Functional Status in Patients With Rheumatoid Arthritis , 2012, Journal of clinical medicine research.

[6]  H. Rafatpanah,et al.  Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis , 2012, Clinical Rheumatology.

[7]  J. Brenol,et al.  Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity , 2012, Scandinavian journal of rheumatology.

[8]  Matthew Larkin,et al.  National Heart Lung and Blood Institute, National Institute of Health , 2012 .

[9]  M. Karimi,et al.  The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls , 2011, International journal of rheumatic diseases.

[10]  G. Ferns,et al.  Investigation of the Association between Metabolic Syndrome and Disease Activity in Rheumatoid Arthritis , 2011, TheScientificWorldJournal.

[11]  G. Ferraccioli,et al.  Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis. , 2011, Swiss medical weekly.

[12]  C. Mok,et al.  Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis , 2011, Arthritis care & research.

[13]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[14]  T. Therneau,et al.  Increased Prevalence of Metabolic Syndrome Associated with Rheumatoid Arthritis in Patients without Clinical Cardiovascular Disease , 2011, The Journal of Rheumatology.

[15]  J. Castillo-Ortiz,et al.  Beyond the joints , 2011, Clinical Rheumatology.

[16]  Quan T. Do,et al.  Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study , 2010, Arthritis research & therapy.

[17]  M. Santos,et al.  Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. , 2010, Acta reumatologica portuguesa.

[18]  G. Plasqui,et al.  Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. , 2010, Maturitas.

[19]  B. Dijkmans,et al.  The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study , 2008, Annals of the rheumatic diseases.

[20]  M. González-Gay,et al.  Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. , 2010, Clinical and experimental rheumatology.

[21]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[22]  B. Dijkmans,et al.  Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome , 2009, Arthritis research & therapy.

[23]  H. John,et al.  Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study , 2009, Arthritis research & therapy.

[24]  J. Robinson.  Colony variability under the spotlight in animal models of arthritis , 2009, Arthritis research & therapy.

[25]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[26]  Jashin J. Wu,et al.  Effects of tumor necrosis factor‐α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis , 2009, Dermatologic therapy.

[27]  G. Kitas,et al.  Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study , 2008, Arthritis research & therapy.

[28]  E. Santana-Sahagún,et al.  Prevalence and Factors Associated With Metabolic Syndrome in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[29]  T. Pincus,et al.  Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. , 2008, Atherosclerosis.

[30]  O. Gualillo,et al.  The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. , 2007, Trends in cardiovascular medicine.

[31]  G. Paolisso,et al.  Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis , 2007, Diabetes & vascular disease research.

[32]  B. Joffe,et al.  Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. , 2007, The Journal of rheumatology.

[33]  J. Papadakis,et al.  Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study , 2006, Annals of the rheumatic diseases.

[34]  P. Dessein,et al.  Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. , 2006, The Journal of rheumatology.

[35]  N. Çakır,et al.  Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. , 2006, The Journal of rheumatology.

[36]  Hyon K. Choi,et al.  Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey. , 2005, The Journal of rheumatology.

[37]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[38]  E. Ford.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. , 2005, Diabetes care.

[39]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[40]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[41]  J. Meigs.  Metabolic syndrome: in search of a clinical role. , 2004, Diabetes care.

[42]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[43]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[44]  A. A. Drosos,et al.  Epidemiology of rheumatoid arthritis. , 2004, Autoimmunity reviews.

[45]  M. Reilly,et al.  The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.

[46]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[47]  Ingram Olkin,et al.  Adjusting for publication bias in the presence of heterogeneity , 2003, Statistics in medicine.

[48]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[49]  Hyon K. Choi,et al.  Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. , 2002, The American journal of medicine.

[50]  B. Joffe,et al.  Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis , 2002, Arthritis research.

[51]  B. Joffe,et al.  The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. , 2002, The Journal of rheumatology.

[52]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[53]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[54]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[55]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[56]  David Moher,et al.  Meta-analysis of Observational Studies in Epidemiology , 2000 .

[57]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[58]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[59]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[60]  E. V. Zaitseva,et al.  Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes. , 1995, Metabolism: clinical and experimental.

[61]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[62]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[63]  L. Wide,et al.  Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. , 1987, Metabolism: clinical and experimental.

[64]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.